| Revenue | SEK 207,5M | +14% |
| EBITDA | SEK 9,1M | +23% |
| Net profit | SEK 923K | -10% |
| Total assets | SEK 50,5M | +3% |
| Equity | SEK 6,7M | +16% |
| Employees | 22 | — |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 112 495 | 129 697 | 141 476 | 181 775 | 207 477 |
| Staff expenses | — | — | — | — | −18 146 |
| EBITDA | −1 982 | 2 580 | 6 387 | 7 397 | 9 126 |
| Depreciation & amort. | −1 967 | −1 865 | −1 709 | −1 541 | −790 |
| EBIT | −3 949 | 715 | 4 678 | 5 856 | 8 336 |
| Net financials | −1 275 | 513 | 734 | 1 342 | 560 |
| Profit before tax | −4 601 | 4 779 | 861 | 896 | 997 |
| Tax | 936 | −990 | −36 | 125 | −74 |
| Net profit | −3 665 | 3 789 | 825 | 1 021 | 923 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 255 630 | 323 554 | 246 627 | 48 825 | 50 467 |
| Equity | 192 | 3 981 | 4 806 | 5 827 | 6 749 |
| Long-term debt | 0 | 0 | 0 | 0 | — |
| Short-term debt | 254 640 | 318 447 | 240 681 | 41 554 | 39 503 |
| Total debt | 254 640 | 318 447 | 240 681 | 41 554 | 39 503 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SJ Chief Auditor | Chief Auditor | 2022 |
| Former (1) | ||
CD Chief Auditor | Chief Auditor | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2020 | |
| Chairman | 2020 | |
| Board of Directors | 2020 | |
| Former (1) | ||
| Board of Directors | 2020 – 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
| Person | Role here | Other companies |
|---|---|---|
| Sten Johan Pharmanson | Chief Auditor | 0 companies |
| Carl Didrik Roos | Chief Auditor | 0 companies |
| Jens Ulrik Kristian Nyström | Board of Directors | 0 companies |
| Lena Margareta Eleonora Nordin | Board of Directors | 0 companies |
| Karl Henric Gunnar Bunge | Chairman | 0 companies |
| Per Daniel Grohman | Board of Directors | 0 companies |